Your account is not claimed yet. You can sign up with ORCID to claim your account.

Noha M Gamaleldin

ORCID

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Venues

Antibiotics (Basel, Switzerland)

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mohamed Abdelwahab Abdelgawad, Ahmed A Hamed, AbdElAziz A Nayl, Mona Shaban E M Badawy, Mohammed M Ghoneim, Ahmed M Sayed, Hossam M Hassan, Noha M Gamaleldin
The Chemical Profiling, Docking Study, and Antimicrobial and Antibiofilm Activities of the Endophytic fungi Aspergillus sp. AP5. Molecules (Basel, Switzerland) 27 (5) (2022)
Noha M Gamaleldin, Hebatallah S Bahr, Yaser A Mostafa, Bryant F McAllister, Amr El Zawily, Che J Ngwa, Gabriele Pradel, Hossam M Hassan, Usama Ramadan Abdelmohsen, Dalal Hussien M Alkhalifah, Wael N Hozzein
Metabolomic Profiling, In Vitro Antimalarial Investigation and In Silico Modeling of the Marine Actinobacterium Strain Rhodococcus sp. UR111 Associated with the Soft Coral Nephthea sp. Antibiotics (Basel, Switzerland) 11 (11) (2022)
Hani A Alhadrami, Raha Orfali, Ahmed A Hamed, Mohammed M Ghoneim, Hossam M Hassan, Ahmed S I Hassane, Mostafa E Rateb, Ahmed M Sayed, Noha M Gamaleldin
Flavonoid-Coated Gold Nanoparticles as Efficient Antibiotics against Gram-Negative Bacteria-Evidence from In Silico-Supported In Vitro Studies. Antibiotics (Basel, Switzerland) 10 (8) (2021)
Hani A Alhadrami, Ahmed M Sayed, Hossam M Hassan, Khayrya A Youssif, Yasser Gaber, Yassmin Moatasim, Omnia Kutkat, Ahmed Mostafa, Mohamed Ahmed Ali, Mostafa E Rateb, Usama Ramadan Abdelmohsen, Noha M Gamaleldin
Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 Therapeutics. Antibiotics (Basel, Switzerland) 10 (5) (2021)

Noha M Gamaleldin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Noha M Gamaleldin